(Total Views: 614)
Posted On: 07/01/2020 1:13:36 PM
Post# of 145890
![Avatar](https://investorshangout.com/images/ProfileImages/167738657_59587_mando klein.jpg)
Guess they will do interim analysis when they have half of the patients, ~180, enrolled. Should be doable by end of July... 120 enrolled already, and casenumbers spiking...
Much better chance getting a stat sig p-value and/or halt for efficacy with n=180.
A 33% death rate in the placebo group and 20% death rate in the leronlimab arm would yield p=0.03. That's doable.
Much better chance getting a stat sig p-value and/or halt for efficacy with n=180.
A 33% death rate in the placebo group and 20% death rate in the leronlimab arm would yield p=0.03. That's doable.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)